Treosulfan

苏消安

Report date: 2025/02/26 12:07:32
NME

Base Information

Drug NameTreosulfan
Drug Alias Name苏消安Dihydroxybusulphantreosulfanum曲奥舒凡二羟马利兰 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agents
TargetsDNA
Therapy Area/IndicationsNijmegen Breakage SyndromePrimary Immunodeficiency DiseasesMetabolism, Inborn Errors +[9] 
Global Approved IndicationsOvarian NeoplasmsHematopoietic stem cell transplantation (HSCT)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date1981/01/06
Country/TerritoryCzechiaUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMedexus Pharmaceuticals IncMedac Gesellschaft Fur Klinische Spezialpraeparate GmbhMedac Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsNijmegen Breakage SyndromePrimary Immunodeficiency DiseasesMetabolism, Inborn Errors +[7] 
Inactive IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute

Other Information

ATC CodeL01AB02
Related LinksWikipediaKEGG